Catalyst Capital Advisors LLC Has $3.71 Million Stake in Cardinal Health, Inc. $CAH

Catalyst Capital Advisors LLC lessened its holdings in Cardinal Health, Inc. (NYSE:CAH) by 4.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 22,078 shares of the company’s stock after selling 949 shares during the period. Catalyst Capital Advisors LLC’s holdings in Cardinal Health were worth $3,709,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. Wellington Management Group LLP lifted its stake in shares of Cardinal Health by 1,666.7% in the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after buying an additional 2,249,241 shares during the last quarter. JPMorgan Chase & Co. lifted its position in Cardinal Health by 40.0% during the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after acquiring an additional 1,193,983 shares during the last quarter. Zurich Insurance Group Ltd FI lifted its position in Cardinal Health by 4,935.9% during the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock worth $130,434,000 after acquiring an additional 927,950 shares during the last quarter. Nuveen LLC acquired a new position in Cardinal Health during the 1st quarter worth $106,065,000. Finally, T. Rowe Price Investment Management Inc. acquired a new position in Cardinal Health during the 1st quarter worth $104,951,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Insider Transactions at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the completion of the sale, the insider owned 48,457 shares of the company’s stock, valued at approximately $7,211,370.74. The trade was a 44.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $2,009,070.00. Following the sale, the insider directly owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is currently owned by insiders.

Cardinal Health Trading Down 0.2%

Shares of CAH opened at $159.21 on Friday. The stock has a 50 day simple moving average of $152.51 and a 200-day simple moving average of $152.43. Cardinal Health, Inc. has a 1 year low of $106.98 and a 1 year high of $168.44. The stock has a market cap of $37.83 billion, a PE ratio of 24.68, a PEG ratio of 1.35 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The business had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm’s revenue for the quarter was up .5% on a year-over-year basis. During the same quarter last year, the company posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend was Wednesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is 31.63%.

Analyst Ratings Changes

A number of research analysts have recently commented on CAH shares. Morgan Stanley reiterated an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Argus set a $189.00 target price on shares of Cardinal Health in a research note on Friday, August 22nd. Leerink Partners upped their target price on shares of Cardinal Health from $186.00 to $187.00 and gave the company an “outperform” rating in a research note on Monday, October 6th. Evercore ISI cut their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research report on Wednesday, August 13th. Finally, UBS Group reaffirmed a “buy” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $166.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.